Insights
Search Results
Client Highlights
7.13.26
Wilson Sonsini Advises Oratomic on $300 Million Series A Financing
On July 7, 2026, Oratomic, a neutral atom quantum computing company focused on building the world’s first fault-tolerant quantum computers, announced that it raised $300 million in its Series A round co-led by ARCH Venture Partners, Spark Capital, and Khosla Ventures, alongside Bezos Expeditions, Index Ventures, General Catalyst, Lowercarbon Capital, Bain Capital, Formation, Nebular, David and Scott Aaronson, and others. Wilson Sonsini Goodrich & Rosati advised Oratomic on the transaction.
Client Highlights
6.24.26
Wilson Sonsini Advises Assort Health on $120 Million Series C
On June 24, 2026, Assort Health, the most widely used AI agents platform for the patient journey, announced a $120 million Series C led by Menlo Ventures at a valuation of $1.2 billion. Assort has now raised more than $222 million to become the standard for healthcare organizations wanting to transform the patient journey with AI. Wilson Sonsini Goodrich & Rosati advised Assort on the transaction.
In addition to Menlo Ventures, investors participating in the Series C financing include Lightspeed Venture Partners, Felicis, First Round Capital, Chemistry, Joe Montana, Tau Ventures, and Quiet Capital.
What began as the first voice AI agent to schedule a specialty appointment is now a platform spanning scheduling, intake forms, referrals, document processing, medication refills, real time eligibility, lab requests, and payments. That expansion has been powered by more than 190 million patient interactions, 62,000 care protocols, and 1.6 million decision pathways, creating the largest proprietary specialty dataset in healthcare.
The Wilson Sonsini team that advised Assort on the financing included Lang Liu, Alex Youssef, Madisyn Klein, and Nara Jo.
For more information, please see Assort’s blog post.
In addition to Menlo Ventures, investors participating in the Series C financing include Lightspeed Venture Partners, Felicis, First Round Capital, Chemistry, Joe Montana, Tau Ventures, and Quiet Capital.
What began as the first voice AI agent to schedule a specialty appointment is now a platform spanning scheduling, intake forms, referrals, document processing, medication refills, real time eligibility, lab requests, and payments. That expansion has been powered by more than 190 million patient interactions, 62,000 care protocols, and 1.6 million decision pathways, creating the largest proprietary specialty dataset in healthcare.
The Wilson Sonsini team that advised Assort on the financing included Lang Liu, Alex Youssef, Madisyn Klein, and Nara Jo.
For more information, please see Assort’s blog post.
Client Highlights
6.18.26
Wilson Sonsini Advises SandboxAQ on Agreement with the U.S. Department of Commerce for $500 Million CHIPS R&D Award
On June 17, 2026, SandboxAQ announced a definitive agreement with the U.S. Department of Commerce's CHIPS Research and Development Office for a $500 million award to address one of the most urgent challenges in American manufacturing: the foreign control of critical materials and chemistries that are essential to semiconductor manufacturing. Wilson Sonsini Goodrich & Rosati advised SandboxAQ on the transaction.
Client Highlights
3.13.26
Firm Advises BlackLine on Agreement with Engaged Capital
On March 10, 2026, BlackLine announced that it entered into a cooperation agreement with Engaged Capital. Under this agreement, BlackLine appointed Storm Duncan and Megan Prichard to its board of directors, and Engaged Capital agreed to various restrictions on its activities at BlackLine. Wilson Sonsini Goodrich & Rosati advised BlackLine on the cooperation agreement.
Client Highlights
3.12.26
Wilson Sonsini Advises Replit on $400 Million Series D
On March 11, 2026, Georgian, a growth-stage B2B investor, announced it has led a $400 million Series D investment in Replit, an AI-powered development platform, valuing the company at $9 billion. G Squared, Prysm Capital, Coatue, Andreessen Horowitz (a16z), Craft Ventures, Y Combinator, Accenture Ventures, Okta Ventures, and Databricks Ventures also participated in the round. Wilson Sonsini Goodrich & Rosati advised Replit on the transaction.
Client Highlights
9.30.25
Wilson Sonsini Advises Assort Health on $76 Million Series B
On September 30, 2025, Assort Health, a comprehensive patient experience platform powered by specialty-specific agentic AI, announced the close of a $76 million Series B financing round led by Lightspeed Venture Partners, with investments by Felicis, First Round Capital, Chemistry, A*, Liquid2, and Quiet. A Wilson Sonsini Goodrich & Rosati team led by Lang Liu, Alex Youssef, and Andrew Lu advised Assort Health on the transaction.
Client Highlights
9.22.25
Wilson Sonsini Advises Netskope on IPO
On September 17, 2025, Netskope, a leader in modern security and networking for the cloud and AI era, announced the pricing of its initial public offering of 47,800,000 shares of its Class A common stock at a public offering price of $19.00 per share. The shares began trading on the Nasdaq Global Select Market on September 18, 2025, under the ticker symbol “NTSK.” The offering closed on September 19, 2025. Additionally, on September 22, 2025, Netskope announced the full exercise of its over-allotment option of 7,170,000 shares of Class A common stock. Wilson Sonsini Goodrich & Rosati advised Netskope on the transaction.
Client Highlights
8.06.25
Wilson Sonsini Advises Skylight Health on $13 Million Fundraise
On August 4, 2025, Skylight Health, a healthcare company committed to improving specialty care for everyone, announced the closing of $13 million in aggregate financing led by Valtruis, with participation from Andreessen Horowitz (a16z) and Allen & Company LLC. Wilson Sonsini Goodrich & Rosati advised Skylight Health on the fundraise.
Client Highlights
4.16.25
Wilson Sonsini Advises Assort Health on $22 Million Series A Funding
On April 16, 2025, Assort Health, a leading AI platform for managing specialty-specific patient phone calls, announced the successful completion of a $22 million Series A funding round. The round was co-led by First Round Capital and Chemistry, with additional support from existing partner Quiet Capital. They join Assort Health’s existing backers, including Four Acres, Tau Ventures, and several notable angel investors, such as senior executives and founders from Athena Health, Astrana Health, Flatiron Health, Infinitus, Mammoth Biosciences, Mercury, PathAI, and Presto. Wilson Sonsini Goodrich & Rosati advised Assort Health on the transaction.
Client Highlights
10.10.24
Wilson Sonsini Advises Relyance on $32 Million Fundraise
On October 10, 2024, Relyance AI, a leading AI-powered data governance platform that provides complete visibility and control over enterprise-wide data, announced it has raised $32 million in Series B funding to scale operations and meet the needs of the exploding use of artificial intelligence in the enterprise. Thomvest Ventures led the round. M12, Microsoft's venture capital fund, also participated, in addition to Cheyenne Ventures and existing investors Menlo Ventures and Unusual Ventures.
Client Highlights
6.05.24
Wilson Sonsini Advises BlackLine on Private Offering of $675 Million Convertible Senior Notes
On May 24, 2024, BlackLine, a leading provider of cloud software that automates and controls financial close and accounting processes, announced an upsized convertible senior note private offering of $600 million due 2029. On June 4, 2024, the initial purchasers of the notes exercised their option to purchase an additional $75 million of the convertible senior notes. Wilson Sonsini Goodrich & Rosati represented BlackLine on the transaction.
Client Highlights
5.23.24
Wilson Sonsini Advises XGS Energy on Oversubscribed $20 Million Series A
On May 21, 2024, XGS Energy (XGS), an innovator in next-generation geothermal energy technology, announced the successful completion of its $20 million Series A financing. The final close was led by Valo Ventures and VoLo Earth Ventures and included financing from new investors B Current Impact Investment, MIH Capital, and individual inside investors, as well as additional funding from existing investor Thin Line Capital. Wilson Sonsini Goodrich & Rosati advised XGS on the transaction.